Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 12, 2012, Pages 2079-2084

  Dong, Jun ^a   Zhou, Guanghua ^a   Tang, Dongfang ^a   Chen, Yanming ^a   Cui, Baoqian ^a   Dai, Xingliang ^a   Zhang, Jinshi ^a   Lan, Qing ^a   Huang, Qiang ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Glioma; Interstitial chemotherapy; Slow releasing microsphere; Temozolomide

Indexed keywords

CARMUSTINE; MICROSPHERE; TEMOZOLOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FEMALE; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SLOW DRUG RELEASE; TREATMENT RESPONSE; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; DELAYED-ACTION PREPARATIONS; FEMALE; GLIOMA; HUMANS; MICE; MICE, NUDE; MICROSPHERES; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84871298731     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1290-3     Document Type: Article

References (11)

1. Banissi C, Ghiringhelli F, Chen L, Carpentier AF (2009) Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model. Cancer Immunol Immunother 58(10): 1627-1634
2. Dong J, Zhang Q, Huang Q, Chen H, Shen Y, Fei X et al (2010) Glioma stem cells involved in tumor tissue remodeling in a xenograft model. J Neurosurg 113(2):249-260
3. Fei XF, Zhang QB, Dong J, Diao Y, Wang ZM, Li RJ et al (2010) Development of clinically relevant orthotopic xenograft mouse model of metastatic lung cancer and glioblastoma through surgical tumor tissues injection with trocar. J Exp Clin Cancer Res 29:84
4. Fleming AB, Saltzman WM (2002) Pharmacokinetics of the carmustine implant. Clin Pharmacokinet 41(6):403-419
5. Hart MG, Grant R, Garside R, Rogers G, Somerville M, Stein K (2011) Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev 3:CD007294
6. Holdhoff M, Grossman SA (2011) Controversies in the adjuvant therapy of high-grade gliomas. Oncologist 16(3):351-358
7. Li XN, Du ZW, Huang Q, Wu JQ (1997) Growth-inhibitory and differentiation-inducing activity of dimethylformamide in cultured human malignant glioma cells. Neurosurgery 40(6):1250- 1258 (discussion 1258-1259)
8. Tomayko MM, Reynold CP (1989) Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 24:148-154
9. Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L, Heiskanen O et al (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41(1):44-48 (discussion 48-49)
10. Whittle IR, Lyles S, Walker M (2003) Gliadel therapy given for first resection of malignant glioma: a single centre study of the potential use of Gliadel. Br J Neurosurg 17(4):352-354
11. Zhang H, Gao S (2007) Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. Int J Pharm 329(1):122-128